
Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

